Flow-diverting Devices for the Treatment of Middle Cerebral Artery Bifurcation Aneurysms
A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 140 participants.
Also called NCT07372612
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 140 participants
- Registry
-
NCT07372612
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07372612. Randomized; no masking; primary purpose treatment. Start 2026-01-20 (anticipated); primary completion 2027-10-15 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Flow-diverting Devices for the Treatment of Middle Cerebral Artery Bifurcation Aneurysms
- Condition
- Aneurysms
- Condition
- Flow Diverter
- Condition
- Middle Cerebral Artery Aneurysm
- Condition
- Coiling Therapy
- Intervention (Procedure)
- Flow diverter
- Intervention (Procedure)
- Stent-assisted coiling
- Lead sponsor
- The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Record details
- Record id
cardio:ct-nct07372612- Content hash
48239e8fc056c1a0cb757b664a12afa590839b4bdbad61b220c8c17990a6b9a5